The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. - Wikidata - wikimedia - TriplyDB

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.

http://www.wikidata.org/entity/Q33316388

about

LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion Roles of transcriptional factor 7 in production of inflammatory factors for lung diseases New drugs for prostate cancer Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the Prostate Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy Aberrant expression of a beta-catenin gain-of-function mutant induces hyperplastic transformation in the mouse cornea.Involvement of members of the cadherin superfamily in cancer Intersection of AHR and Wnt signaling in development, health, and disease.Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration Transcriptional regulation of the cyclin D1 gene at a glance.Wnt3a: functions and implications in cancer.A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium Androgen receptor regulates SRC expression through microRNA-203 Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.Effect of dihydrotestosterone on the expression of mucin 1 and the activity of Wnt signaling in mouse corneal epithelial cells The changing therapeutic landscape of castration-resistant prostate cancer.Androgen action and metabolism in prostate cancer.Mechanisms of acquired resistance to targeted cancer therapies.TCF/LEFs and Wnt signaling in the nucleus.Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research.miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.Recurrent gene fusions in prostate cancer: their clinical implications and uses.To die or to survive, a fatal question for the destiny of prostate cancer cells after androgen deprivation therapy.Wnt signaling in castration-resistant prostate cancer: implications for therapy.Leading causes of castration-resistant prostate cancer.Adaptive stress signaling in targeted cancer therapy resistance.TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.Revisiting the role of Wnt/β-catenin signaling in prostate cancer.Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.

P2860

Q24313620-3A340949-6FD8-48EF-925A-8669F1BFB73A Q26796409-539E8B45-4ED9-43FF-8427-FA7A9480079F Q26827515-469AD02A-EB04-4839-9BC2-CD473EC623D4 Q27312119-6F208C30-4814-490E-A769-2DBE956791F8 Q28076060-E7BC52D5-3508-417D-B644-76D3999EA72B Q28487784-7768D4A1-B84B-4306-BF71-DDC76C5E79CA Q29010479-B2146FCB-5F7B-47ED-9763-B5C5A7B9C17D Q33763816-6F988BBB-1FF5-4289-9FCD-B7BB678FAC66 Q33899441-7524F2B2-FCB9-45E6-A361-4C891EF1194F Q34486670-1E03E5DB-6FD3-4307-851D-2BCB612C239D Q34495620-A9F14608-248A-44E3-9B73-28A99A429E9E Q34550256-3B6FDB66-C5C7-42F7-8689-C691623BE1C5 Q34562695-38A90138-79B9-4DB9-97AC-26B757ACDC8E Q34643472-C372BEAF-6D2D-4497-A3E9-166AD58A3A2A Q35006864-D0FA5FAB-1F48-4956-AD73-6F91B6D817D9 Q35624078-A3FA8842-6991-4B57-8CCD-4A8DAA06CAEF Q35985157-FF7B18AE-86EB-4787-814A-CA208E820F9C Q36121065-7781A599-D401-4266-A901-79A75A4CD298 Q36674584-E06FAF15-C78C-41A8-905E-2A06970A4D72 Q36796016-7C926A93-4423-4241-9AD6-F2123BAD44E1 Q36827512-6DA2D460-CF89-4ECC-BA12-5B28B222E0C4 Q37215956-48808637-13BC-4B89-A0F6-5A494490B8E3 Q37295473-B088441E-0D0D-4E6C-8935-7439A413E210 Q37295639-66693E09-0D23-4E00-9812-61325197DD8F Q37407566-0C5A3B8D-823C-48D0-AFCF-041A4B45FED1 Q37485814-BC021F19-BD58-4C45-8252-A7F60F095B51 Q37913983-CC08BB46-0031-45A9-8F10-7C44D4196526 Q37997571-978C5C28-E3C6-4A18-AAB9-CDD072A23124 Q38034816-BEB54187-4E75-4D17-8583-BB999095370E Q38048246-67DE4BA7-89F1-4AF5-AAD4-DBFE30F200A1 Q38060099-CEE8902B-F8B6-4C88-9421-6612FD7453BD Q38096240-DC11F685-507B-4875-BDC8-3633F5B69369 Q38102618-AE24624D-685F-4E0A-9533-353A7CDEC5A7 Q38161350-00CAC319-99F1-4AA0-82D5-67CB1783DD25 Q38241850-6488B860-9999-4388-8219-983061A8D729 Q38341864-E0F8B431-A870-42DC-867E-AB17A90DAA37 Q38363739-83D783DE-860E-4EA4-A2B1-7AE9D5EAADED Q38950688-F861DD64-AF29-42D1-AE4B-80D3A168E844 Q39131794-874E25CB-70F9-4DD5-97CC-40AC1B407BA1 Q39154924-2507DB12-4A9A-4BD6-9495-DA516A0B5DF3

P2860

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.

http://www.wikidata.org/entity/Q33316388

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The androgen receptor can sign ...... astration levels of androgens.

@ast

The androgen receptor can sign ...... astration levels of androgens.

@en

The androgen receptor can sign ...... astration levels of androgens.

@nl

type

label

The androgen receptor can sign ...... astration levels of androgens.

@ast

The androgen receptor can sign ...... astration levels of androgens.

@en

The androgen receptor can sign ...... astration levels of androgens.

@nl

prefLabel

The androgen receptor can sign ...... astration levels of androgens.

@ast

The androgen receptor can sign ...... astration levels of androgens.

@en

The androgen receptor can sign ...... astration levels of androgens.

@nl

P1433

Q33316388-8809A6B4-6385-46E4-83A1-1A8E0D68F681

P1476

Q33316388-12C94CEA-4A46-4C5C-8605-CD3FB2D38C7D

P2093

Q33316388-04EC7617-5993-44D8-A043-D457738C664A

Q33316388-706FEC06-AB18-44F9-9C4E-31B339B96551

Q33316388-7F7FC912-867F-435B-95AF-5DDB6939CB7F

Q33316388-8511793B-3903-464E-A5B6-217B15A5A541

Q33316388-8EA2BA03-8895-4109-A535-327FE1C25409

Q33316388-D02CDFC9-50B1-4414-8E49-9F99A7D95E7A

Q33316388-F09FEAEA-4B16-4A1B-9AEB-0A662B096B60

Q33316388-F33C0E3C-CDB3-4239-AFA7-88AEA39617E4

P2860

Q33316388-00D3CB33-DCC6-45D9-89B6-CCB72733DAB7

Q33316388-0225328A-18D1-48F1-A2DD-2429A637D0FB

Q33316388-030B14A5-1116-4BC3-9B73-AA47598C482E

Q33316388-070BF7D0-A994-47CA-BB76-B7F3FB253AB4

Q33316388-0E18B12D-2722-4989-9208-1215F6BBC3A7

Q33316388-10270CEC-647D-4BEA-A965-78C52E86816E

Q33316388-12658D85-8823-44AD-9F04-AD0F3D13C1AB

Q33316388-1B67B347-AC64-4124-9775-FF90C90B713F

Q33316388-1BB1D356-2AAB-48D8-9BC8-0EEB934CEF4E

Q33316388-1CB44959-5426-4EEA-BE42-0F766497F095

P2888

Q33316388-DD13CAB1-4791-44AD-B427-D5DE3ADEFFD1

P304

Q33316388-AFB02232-C62E-48B0-8B9B-2F83B7CA5DA5

P31

Q33316388-AD20AE3B-3DCD-4AB7-857F-6363FC58CBA4

P356

Q33316388-BF7746B7-6895-4DA9-878B-16E73A44BCF9

P478

Q33316388-34A1949E-FA42-4F8B-A3B6-07872B3AE568

P577

Q33316388-F0AB7AEA-66FD-4508-86DE-4A13DADA92C9

P5875

Q33316388-965244E3-0BEA-425F-AF60-07C2EF82C3A5

P6179

Q33316388-198B9F60-6149-4E19-AD86-172FBDF7BA11

P698

Q33316388-A3A3DD35-F8BE-41B5-AECA-EC63DF661598

P932

Q33316388-DA9ECF3C-FDD7-41C4-B5FD-F5CD2C6EE548

P356

P1433

BMC Cell Biology

P1476

The androgen receptor can sign ...... astration levels of androgens.

@en

P2093

Cheryl A Rizzo

http://www.w3.org/2001/XMLSchema#string

J Suso Platero

http://www.w3.org/2001/XMLSchema#string

Liang Schweizer

http://www.w3.org/2001/XMLSchema#string

Marco M Gottardis

http://www.w3.org/2001/XMLSchema#string

Qiuyan Wu

http://www.w3.org/2001/XMLSchema#string

Ricardo M Attar

http://www.w3.org/2001/XMLSchema#string

Tai-An Lin

http://www.w3.org/2001/XMLSchema#string

Thomas E Spires

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-catenin affects androgen receptor transcriptional activity and ligand specificity

A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4

Identification of c-MYC as a target of the APC pathway

Wnt/Wingless signaling through beta-catenin requires the function of both LRP/Arrow and frizzled classes of receptors

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

The Wnt signaling pathway in development and disease

Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells

Linking beta-catenin to androgen-signaling pathway

Molecular determinants of resistance to antiandrogen therapy

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2121-9-4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5633829

http://www.w3.org/2001/XMLSchema#string

P6179

1043120614

http://www.w3.org/2001/XMLSchema#string

P698

18218096

http://www.w3.org/2001/XMLSchema#string

P932

2246119

http://www.w3.org/2001/XMLSchema#string